08/21/2026
We invite submissions to an upcoming special collection titled, “Peptide-based Therapeutics for Tumor Immunomodulation.”
Immunomodulatory proteins and peptides provide a means to directly influence tumor microenvironment and can be combined with chemo- and radiotherapeutics as a novel method to treat several cancers. Original research highlighting design and development of peptide-based therapeutics for tumor microenvironment modulation along with tumor targeting, drug delivery, nanotherapeutics and imaging in cancer research will be considered for this section. Manuscripts demonstrating peptide-based therapeutics (including repurposed peptide-based drugs) as delivery carriers for immunomodulatory molecules or peptides as immunomodulatory agents are especially welcome. Research papers that clearly demonstrate mechanistic studies of immunomodulatory pathways in vitro and in animal models using peptide-based therapeutics and/or theranostics-a personalized cancer treatment approach combining "therapeutics" and "diagnostics", as well as potentially translatable to human use and/or clinically (including phase 0-II clinical trials) are highly encouraged.
Learn more and submit your research: https://ow.ly/y7p350ZC0x7